Search Within

Solid Tumor Oncology Division

  1. "Clifford Hudis"
Formats
  1. Journal Article (483)
  2. Meeting Abstract (393)
  3. Book Section (15)
  4. Conference Paper (10)
  5. Book Whole (2)
  6. Guidelines (1)
  7. Review (1)
Groups
  1. Breast Medicine Service (905)
  2. Department of Medicine (905)
  3. Survivorship Research (905)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (318)
  5. Epidemiology and Biostatistics (242)
  6. Biostatistics Service (221)

More Groups

People
  1. Clifford Hudis (905)
  2. Larry Norton (293)
  3. Sujata Patil (141)
  4. Andrew Seidman (116)
  5. Chau Dang (111)
  6. Maura Dickler (102)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (5)
  6. 2019 (9)

More Years

Publications
  1. Journal of Clinical Oncology (246)
  2. Cancer Research (108)
  3. Breast Cancer Research and Treatment (77)
  4. Clinical Cancer Research (33)
  5. Cancer (30)
  6. Annals of Oncology (29)

More Publications

Publishers
  1. American Society of Clinical Oncology (249)
  2. American Association for Cancer Research (163)
  3. Springer (100)
  4. Elsevier Inc. (84)
  5. Oxford University Press (55)
  6. Wiley Blackwell (45)

More Publishers

Results (905)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
    Journal Article

    Albain, K. S.; Barlow, W. E.; Shak, S.; Hortobagyi, G. N.; Livingston, R. B.; Yeh, I. T.; Ravdin, P.; Bugarini, R.; Baehner, F. L.; Davidson, N. E.; more...
    Lancet Oncology (2010)

    Fulltext@MSK | Save
  • Evaluation and treatment of breast cancer
    Book Section

    McArthur, H. L.; Hudis, C. A.
    In Stubblefield, M. D.; O'Dell, M. W. (Eds.) Cancer Rehabilitation: Principles and Practice. 1st ed (2009)

    Fulltext@MSK | Save
  • Safety of a novel capecitabine dosing schedule when combined with lapatinib in patients with HER2-positive metastatic breast cancer refractory to trastuzumab
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Modi, S.; Fornier, M.; Lake, D.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Sexual dysfunction in women with breast cancer: Prevalence and severity
    Meeting Abstract

    Goldfarb, S. B.; Dickler, M.; Sit, L.; Fruscione, M.; Barz, T.; Atkinson, T.; Hudis, C.; Basch, E.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Dose-dense (DD) cyclophosphamide, methotrexate, and fluorouracil (CMF) at 14-day intervals: A pilot study of every 14- and 10-11-day dosing intervals for women with early-stage breast cancer
    Meeting Abstract

    Drullinsky, P.; Fornier, M. N.; Sugarman, S.; D'Andrea, G.; Troso-Sandoval, T.; Seidman, A. D.; Yuan, J.; Patil, S.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Randomized phase II trial of nanoparticle albumin-bound paclitaxel in three dosing schedules with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer (MBC)
    Meeting Abstract

    Conlin, A. K.; Hudis, C. A.; Bach, A.; Moynahan, M.; Lake, D.; Forero-Torres, A.; Wright, G.; Hackney, M.; Clawson, A.; Seidman, A. D.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Evaluation of the correlation of baseline blood pressure (BP) and plasma renin activity (PRA) with bevacizumab (B)-mediated hypertension in patients with early-stage breast cancer
    Meeting Abstract

    Dickler, M. N.; McArthur, H. L.; Nulsen, B.; Patil, S.; Sealey, J.; Laragh, J.; Merali, C.; Steingart, R.; Hudis, C.; Rugo, H.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase IIb double-blind, randomized, placebo-controlled trials for the efficacy and safety of sorafenib in patients (pts) with metastatic or locally advanced breast cancer (BC): Review of the Trials to Investigate the Effects of Sorafenib in BC (TIES) program
    Meeting Abstract

    Baselga, J.; Gianni, L.; Gradishar, W. J.; Hudis, C.; Perez, E. A.; Piccart-Gebhart, M.; Schwartzberg, L. S.; Sledge, G.; Fleming, T. R.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • The impact of obesity on adherence to the National Comprehensive Cancer Network (NCCN) guidelines recommending chemotherapy for patients with operable breast cancer
    Meeting Abstract

    Brewster, A. M.; Etzel, C.; Zhou, R.; Wong, Y.; Edge, S. B.; Blayney, D. W.; Wilson, J.; Hudis, C.; Weeks, J. C.; Theriault, R. L.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Dose-dense adjuvant doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction
    Journal Article

    Morris, P. G.; Dickler, M.; Mcarthur, H. L.; Traina, T.; Sugarman, S.; Lin, N.; Moy, B.; Come, S.; Godfrey, L.; Nulsen, B.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save